---
schema_version: "secwatch.filing_event.v1"
accession: "0001903596-24-000380"
form_type: "8-K"
ticker: "KAYS"
cik: "0001530746"
company_name: "Kaya Holdings, Inc."
filed_at: "2024-06-07T23:59:59+00:00"
generated_at: "2026-06-01T05:33:19.313224+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Kaya Holdings opens The Sacred Mushroom psilocybin treatment center in Portland, accepting appointments

## Summary
- Majority-owned subsidiary Fifth Dimension Therapeutics begins accepting appointments at The Sacred Mushroom in Portland, Oregon.
- 11,000 sq ft facility on 7th floor offers customized psychedelic experiences via proprietary 'Synergy by Design'.
- Facility targets mental health conditions including PTSD, anxiety, trauma, and addictions; also offers group and corporate events.
- U.S. behavioral health market was $83B in 2022, projected to exceed $136B by 2032 per Precedence Research.
- CEO Craig Frank calls opening an important milestone for KAYS.

## SEC filing metadata
- accession: 0001903596-24-000380
- form_type: 8-K
- ticker: KAYS
- cik: 0001530746
- company_name: Kaya Holdings, Inc.
- filed_at: 2024-06-07T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1530746/000190359624000380/0001903596-24-000380-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1530746/000190359624000380/kays_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001903596-24-000380
- JSON: https://secwatch.observer/filing/0001903596-24-000380.json
- Plain text: https://secwatch.observer/filing/0001903596-24-000380.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.